semaglutide and graves disease sem

Dr. Grace Lee logo
Dr. Grace Lee

semaglutide and graves disease Both drugs are considered safe to take together - Semaglutidecause hyperthyroidism semaglutide causing any kind of thyroid cancer Navigating the Intersection of Semaglutide and Graves' Disease: What You Need to Know

Cansemaglutideraise TSH levels The emergence of semaglutide as a powerful tool for weight management and diabetes control has led to widespread interest, but also to important questions about its interactions with existing health conditions. One area of particular focus is the relationship between semaglutide and Graves' disease, an autoimmune disorder that affects the thyroid gland. While research is ongoing, understanding the current scientific consensus and potential implications is crucial for patients and healthcare providers alike.

The primary concern often discussed in the context of semaglutide and thyroid health revolves around the potential for thyroid tumors and thyroid cancer. It's important to note that early rodent studies did suggest a link, leading to a "black box" warning on some medications containing semaglutide. However, extensive human clinical studies, including a landmark study published in The Journal of Clinical Endocrinology & Metabolism, have found no convincing link to common thyroid cancers and suggest that semaglutide does not promote thyroid cancer. In fact, some research indicates it may even suppress tumors. Despite these findings, it is still recommended that individuals with a personal or family history of thyroid cancer or medullary thyroid carcinoma discuss the use of semaglutide with their healthcare provider.Implications of GLP-1 Receptor Agonist on Thyroid Function A Mayo Clinic study, for instance, found no overall increase in thyroid cancer risk with GLP-1 receptor agonist (GLP1-RA) therapy, suggesting early diagnoses likely reflect increased screening.

For individuals with pre-existing thyroid conditions such as Graves' disease, Hashimoto's thyroiditis, or those requiring thyroid medication, the safety of semaglutide is a key consideration.2024年9月5日—While researchers have found no incidence to date ofsemaglutide causing any kind of thyroid cancerin humans, the earliest laboratory research ... Current data suggests that for many, Ozempic is likely safe to take, even if you have a thyroid condition. The medications used to treat these conditions generally do not interact negatively. Moreover, semaglutide's anti-inflammatory properties may indirectly promote better thyroid health by reducing systemic inflammation, although it's important to remember that semaglutide does not treat the underlying thyroid dysfunction itself. One study even indicated that semaglutide use could be associated with a lower incidence of hypothyroidism.Semaglutide therapy and iatrogenic thyrotoxicosis - PMC - NIH

However, there are nuances to consider作者:S Capuccio·2024·被引用次数:28—The analysis concluded that the combination of cagrilintide andsemaglutidewas the most effective GLP-1 RAs in reducing body weight.. Some retrospective analyses have suggested a possible association between GLP-1RA use and lower incidence of hypothyroidism. Conversely, other research indicates that semaglutide treatment can significantly alter thyroid hormones and TSH levels in patients with obesity, with some effects being reversible post-discontinuation. A specific case report highlighted suppressed thyroid stimulating hormone levels after initiating subcutaneous semaglutide, leading to the conclusion that an influence of semaglutide on thyroid function is possible and that thyroid function tests are suggested in patients receiving both levothyroxine and semaglutide.Semaglutide-induced Subclinical Hypothyroidism: A Case ... Another study found that GLP-1 medications can reduce TSH levels in hypothyroid patients who lose weight, with semaglutide showing the greatest effect.

Regarding Graves' disease specifically, while direct causative links between semaglutide and the onset or worsening of Graves' disease are not firmly established in large-scale studies, some anecdotal reports exist, though these are often countered by evidence suggesting a limited or no role for the medication. For instance, one user's negative experience was deemed unlikely to be related to semaglutide by experts.2024年1月4日—Semaglutide's anti-inflammatory propertiesmay indirectly promote better thyroid healthby reducing systemic inflammation. While not a direct ... Updates on Graves' disease continue to emerge, focusing on clinical trials for conventional treatments and advancements.

It's also worth noting that some patients on semaglutide have experienced iatrogenic hyperthyroidismGLP-1RA and thyroid cancer: New study suggests .... This highlights the importance of careful monitoring, especially in individuals with pre-existing thyroid conditions. If you are on levothyroxine for hypothyroidism, it is advisable to discuss the potential impact of semaglutide on your thyroid medication dosage and overall thyroid balance with your doctor. The guidance is that both drugs are considered safe to take together, but adjustments may be necessarySemaglutide Injection: MedlinePlus Drug Information.

In summary, while semaglutide has shown promise for many, its use in individuals with Graves' disease or other thyroid conditions warrants careful consideration and open communication with healthcare professionals. The current body of evidence suggests that semaglutide is generally safe for individuals with thyroid issues, and the feared link to thyroid cancer has not been substantiated in human studies.Possible Side Effects of Ozempic ® (semaglutide) Injection However, potential impacts on thyroid hormones and TSH levels necessitate vigilant monitoring and personalized treatment plans. Continuous advancements in research will undoubtedly further clarify the intricate relationship between these powerful medications and thyroid health.

Log In

Sign Up
Reset Password
Subscribe to Newsletter

Join the newsletter to receive news, updates, new products and freebies in your inbox.